MedTrace Logo

Prehabilitation to Patients With Prostate Cancer

NCT07162987 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-09-09

No results posted yet for this study

Summary

The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are:

* Are patients and their close relatives willing to take part in prehabilitation?
* What is the acceptability and feasibility of the prehabilitation intervention, seen from the perspectives of patients, their close relatives, and healthcare professionals?
* Are the planned data collection methods feasible, and are there indications of a clinical effect?

Participants will:

* Take part in 12 weeks of physical exercise training
* Attend a 4-day residential prehabilitation intervention, where they receive education and do exercises. After 12 weeks, it is possible to take part in a voluntary follow-up session.
* Patients will respond to questionnaires about their health, symptoms, and quality of life. Patients and their close relatives will attend a group interview. Patients will also complete an exercise diary and brief physical tests

Conditions

  • Prostate Cancer (Diagnosis)

Interventions

BEHAVIORAL

Prehabilitation

Please refer to arm description

Sponsors & Collaborators

  • REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care

    collaborator OTHER

  • Vejle Hospital

    collaborator OTHER

  • Esbjerg Municipality

    collaborator OTHER_GOV

  • Esbjerg Hospital - University Hospital of Southern Denmark

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07162987 on ClinicalTrials.gov